Successful discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis in real-world settings-Reference-Cited by-同舟云学术

Successful discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis in real-world settings

Published:2021-03-01 Issue:4 Volume:31 Page:790-795
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Ochiai Moeko¹,Tanaka Eiichi¹,Sato Eri¹²,Inoue Eisuke¹³,Abe Mai¹,Saka Kumiko¹,Sugano Eri¹,Sugitani Naohiro¹,Higuchi Yoko¹,Yamaguchi Rei¹,Sugimoto Naoki¹,Ikari Katsunori⁴,Nakajima Ayako¹⁵,Yamanaka Hisashi¹⁶,Harigai Masayoshi¹

Affiliation:

1. Department of Rheumatology, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan

2. Keyaki Total Clinic, Chiba, Japan

3. Research Administration Center, Showa University, Tokyo, Japan

4. Department of Orthopedics, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan

5. Center for Rheumatic Diseases, Mie University Hospital, Mie, Japan

6. Rheumatology, Sanno Medical Center, Tokyo, Japan

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14397595.2021.1883252

Reference28 articles.

1. Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study

2. Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational study

3. Discontinuation of infliximab in rheumatoid arthritis patients in clinical remission

4. Effect of discontinuing TNFα antagonist therapy in patients with remission of rheumatoid arthritis

5. Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and predictors of sustained remission/low disease activity after discontinuation of induction or maintenance treatment with tumor necrosis factor inhibitors in rheumatoid arthritis: a systematic and scoping review;Arthritis Research & Therapy;2023-11-20

2. Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy;Frontiers in Pharmacology;2023-09-25